PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of npgopennature.com homepage
The Journal of Investigative Dermatology
 
J Invest Dermatol. 2013 March; 133(3): 793–802.
Published online 2012 October 25. doi:  10.1038/jid.2012.370
PMCID: PMC3572452

Lysophosphatidic Acid Promotes Cell Migration through STIM1- and Orai1-Mediated Ca2+i Mobilization and NFAT2 Activation

Abstract

Lysophosphatidic acid (LPA) enhances cell migration and promotes wound healing in vivo, but the intracellular signaling pathways regulating these processes remain incompletely understood. Here we investigated the involvement of agonist-induced Ca2+ entry and STIM1 and Orai1 proteins in regulating nuclear factor of activated T cell (NFAT) signaling and LPA-induced keratinocyte cell motility. As monitored by Fluo-4 imaging, stimulation with 10 μx2133 LPA in 60 μx2133 Ca2+o evoked Ca2+i transients owing to store release, whereas addition of LPA in physiological 1.2 mx2133 Ca2+o triggered store release coupled to extracellular Ca2+ entry. Store-operated Ca2+ entry (SOCE) was blocked by the SOCE inhibitor diethylstilbestrol (DES), STIM1 silencing using RNA interference (RNAi), and expression of dominant/negative Orai1R91W. LPA induced significant NFAT activation as monitored by nuclear translocation of green fluorescent protein-tagged NFAT2 and a luciferase reporter assay, which was impaired by DES, expression of Orai1R91W, and inhibition of calcineurin using cyclosporin A (CsA). By using chemotactic migration assays, LPA-induced cell motility was significantly impaired by STIM1, CsA, and NFAT2 knockdown using RNAi. These data indicate that in conditions relevant to epidermal wound healing, LPA induces SOCE and NFAT activation through Orai1 channels and promotes cell migration through a calcineurin/NFAT2-dependent pathway.

Introduction

Lysophosphatidic acid (LPA) is a potent bioactive phospholipid that regulates diverse cellular processes including proliferation, differentiation, adhesion, and migration among several cell types, principally through interaction with a range of specific cell-surface receptors (Noguchi et al., 2009). In the context of wound repair, LPA is released into acute wounds from serum and platelets (Eichholtz et al., 1993; Inoue et al., 1995; Goetzl and An, 1998; Baker et al., 2002; Mazereeuw-Hautier et al., 2005) and is present in physiologically relevant concentrations in blister fluid (Mazereeuw-Hautier et al., 2005). LPA has been shown to promote migration of cultured epidermal keratinocytes (Sauer et al., 2004) and to enhance wound closure following topical application to experimental wounds in rats and mice (Demoyer et al., 2000; Balazs et al., 2001). LPA-induced signaling is complex and involves the activation of specific G protein–coupled receptors (LPA1–6), as well as transactivation of other plasma membrane receptors (Sekharam et al., 2000; Sauer et al., 2004; Noguchi et al., 2009). Binding of LPA to its specific receptors also elicits mobilization of intracellular calcium (Ca2+i) from IP3-dependent stores and influx of extracellular Ca2+ (Ca2+o) mediated by incompletely defined mechanisms (Noguchi et al., 2009). Keratinocytes are known to express LPA1–3 and respond to LPA with Ca2+ transients (Anliker and Chun, 2004; Roedding et al., 2006; Ross et al., 2007; Lichte et al., 2008), but the physiological relevance of LPA-induced Ca2+ fluxes and the downstream signaling pathways in mediating specific physiological effects remain to be defined.

Recent studies have identified the endoplasmic reticulum Ca2+ sensor STIM1 and the plasma membrane channel protein Orai1 as critical components of agonist-induced Ca2+ entry (Frischauf et al., 2008; Martin et al., 2009), as well as being crucial for tumor cell migration (Vassilieva et al., 2008; Yang et al., 2009; Zuo and Chen, 2009). Our previous data suggested a role for STIM1 in mediating Ca2+ entry in keratinocytes (Ross et al., 2007, 2008), but there is currently no information regarding the role of STIM1 or Orai1 in regulating keratinocyte migration.

The calcineurin/nuclear factor of activated T cell (NFAT) signaling cascade is characteristically recruited by the sustained Ca2+i mobilization observed during Ca2+ entry (Macian, 2005; Gwack et al., 2007). NFAT factors have been determined to be crucial for regulating cell motility in several cell types (Jauliac et al., 2002; Corral et al., 2007). We and others have shown that NFAT factors are functionally active in keratinocytes and epidermis, and calcineurin/NFAT activity has also been directly implicated in the regulation of keratinocyte growth and differentiation (Santini et al., 2001; Al-Daraji et al., 2002; Mammucari et al., 2005). The relationship between Ca2+ fluxes and NFAT activation in keratinocytes remains to be determined, and furthermore, the involvement of calcineurin/NFAT signaling in LPA-induced cell motility remains unknown.

In this study, we therefore investigated the hypothesis that LPA promotes keratinocyte migration through Ca2+i mobilization and examined the role of STIM1, Orai1 and calcineurin/NFAT recruitment within these physiological phenomena.

Results

Stimulation of keratinocytes with LPA in physiological Ca2+o triggers Ca2+ entry

As previous studies in lymphocytes have indicated that sustained increases in Ca2+i encountered during Ca2+ entry (Gwack et al., 2007) are required for NFAT activation (Dolmetsch et al., 1997), we first determined the experimental conditions in which LPA could evoke Ca2+ entry in primary keratinocytes. LPA is known to induce short transient elevations of Ca2+i due to the release of Ca2+ from intracellular stores, but Ca2+ entry has not been reported (Ross et al., 2007, 2008; Lichte et al., 2008). As the relevance of Ca2+o in the regulation of LPA-induced Ca2+ mobilization in keratinocytes has largely been ignored, we investigated LPA-induced Ca2+ mobilization in the context of varying Ca2+o.

Keratinocytes were routinely cultured in medium containing 60 μx2133 Ca2+o. The addition of 10 μx2133 LPA in these conditions induces a transient (±200 seconds) peak elevation of Ca2+i (Figure 1a), indicative of store release as expected (Ross et al., 2007, 2008; Lichte et al., 2008). Adjustment of the Ca2+o to 1.2 mx2133 in the absence of LPA resulted in a weak increase in Ca2+i (Figure 1a) over an extended period of time (>10 minutes), similar to previous reports (Bikle et al., 1996; Tu et al., 2001). To mimic the contact of keratinocytes with LPA in a serum-relevant Ca2+o, we analyzed the effect of adding LPA in 1.2 mx2133 Ca2+o. Under these conditions, LPA induced a transient peak in Ca2+i, followed by a sustained (>10 minutes) plateau elevation of Ca2+, which suggests store release coupled to entry of extracellular Ca2+ (Figure 1a).

Figure 1
Lysophosphatidic acid (LPA) stimulation in 1.2 mx2133 Ca2+o evokes Ca2+ entry. Keratinocytes were subjected to Ca2+i imaging. (a) Stimulation with 10 μx2133 LPA in 60 μx2133 or ...

We then used an addback protocol to verify the occurrence of Ca2+ entry by uncoupling store release from influx (Figure 1b). Manganese quenching (Sage et al., 1989) by the addition of 500 μx2133 MnCl2 during the plateau phase quickly reduced Ca2+i to the baseline level (Figure 1b). In addition, we used Ca2+ entry–blocking pharmacological agents to further define the Ca2+-mobilizing effect of LPA. We initially validated the pharmacological agents through studies on thapsigargin (Tg)-induced Ca2+ entry. Although 2-aminoethoxydiphenyl borate has been classically used to block store-operated Ca2+ entry (SOCE), this molecule is increasingly recognized to be rather nonspecific (Schindl et al., 2008). We found that 2-aminoethoxydiphenyl borate did not block Tg-induced Ca2+ entry at a variety of concentrations (data not shown). Similarly, we found that the addition of gadolinium ions (Gd3+) did not reliably block Tg-induced SOCE (data not shown). We therefore used the lesser known SOCE inhibitor diethylstilbestrol (DES), which blocks SOCE channels and inwardly rectifying current but exerts no effect on TRPM channels (Zakharov et al., 2004; Dobrydneva et al., 2010). DES was indeed found to inhibit Tg-induced SOCE in keratinocytes (Figure 1c), and the addition of DES during the plateau phase of LPA-induced Ca2+ entry blocked further entry (Figure 1b), providing further evidence that LPA induces Ca2+ entry in keratinocytes through SOCE channels.

To further characterize the impact of Ca2+o on LPA-induced Ca2+ mobilization, keratinocytes were incubated in medium containing 1.2 mx2133 Ca2+ for an extended time (45 minutes) before LPA stimulation. Under these conditions, LPA induced store release (Figure 1d) in a manner similar to previous studies (Ross et al., 2007; Lichte et al., 2008), but no entry was apparent during the observed time span (>10 minutes). Next, we uncoupled the addition of agonist and Ca2+ by adjusting the Ca2+o to 1.2 mx2133 for 60 seconds before adding LPA (Roedding et al., 2006) (Figure 1e). There was no significant difference detected between Ca2+i fluxes observed in these conditions and when LPA and millimolar Ca2+ were added simultaneously, suggesting that simultaneous stimulation of LPA receptors and adjustment to millimolar Ca2+ does not just overwhelm the plasma membrane channels and thereby cause nonspecific entry.

LPA induces nuclear translocation of NFAT2 and upregulates NFAT transcriptional activity

We then investigated the effect of LPA on NFAT activation. First, we used a real-time live-cell imaging method to simultaneously analyze Ca2+i variations (using FuraRed) and NFAT activation (by visualizing nuclear translocation of green fluorescent protein (GFP)-tagged NFAT2). The proof-of-principle of this method was achieved by triggering Tg-mediated SOCE, which resulted in a sustained Ca2+i increase as expected. This correlated with progressive and strong nuclear accumulation of NFAT2-GFP within 10 minutes of exposure (Figure 2a).

Figure 2
LPA-induced Ca2+ mobilization correlates with nuclear translocation of GFP-tagged nuclear factor of activated T cell 2 (NFAT2). Keratinocytes expressing green fluorescent protein (GFP)-tagged NFAT2 were subjected to Ca2+i imaging using ...

Simultaneous stimulation with LPA and 1.2 mx2133 Ca2+o resulted, as expected, in Ca2+ store release coupled to entry, which correlated with progressively increasing nuclear accumulation of NFAT2 (Figure 2b). Adjustment of Ca2+o to 1.2 mx2133 did not induce significant NFAT2 translocation within 10 minutes of treatment (Figure 2c). In all experimental conditions, nuclear translocation of NFAT2 was prevented by preincubating the cells for 1 hour with the calcineurin inhibitor cyclosporin A (CsA, 1 μx2133) before agonist challenge (data not shown).

Second, we investigated the effect of LPA on NFAT activity using a luciferase reporter under the transcriptional control of NFAT (Wilkins et al., 2004). LPA stimulation in 1.2 mx2133 Ca2+o prompted a significant and sustained upregulation of NFAT activity to a level ~10-fold over baseline within 4 hours after stimulation (Figure 3a). In comparison, LPA stimulation in 60 μx2133 Ca2+o increased NFAT activity within 4 hours before reaching a plateau level ~2.5-fold over the control level (Figure 3a). Adjustment of Ca2+o to 1.2 mx2133 in the absence of LPA induced a weak increase of NFAT activity (~2.5-fold) over 24 hours (Figure 3a). As shown in Figure 3b, preincubation of keratinocytes for 1 hour with 1 μx2133 CsA before LPA and millimolar Ca2+o challenge prevented the induction of NFAT transcriptional activity. To further investigate the role of Ca2+ entry in LPA-induced NFAT activation, DES was added during agonist challenge, which resulted in a significantly impaired induction of NFAT activity (Figure 3c).

Figure 3
Lysophosphatidic acid (LPA)-induced Ca2+ entry triggers sustained calcineurin-dependent upregulation of nuclear factor of activated T cell (NFAT) transcriptional activity. (a) Keratinocytes were stimulated as indicated and assessed for NFAT-dependent ...

Characterization of the mechanism of LPA-induced Ca2+ entry

The implication of STIM1 in LPA-induced Ca2+ entry was studied by analyzing the effect of RNA interference (RNAi-mediated) knockdown of STIM1 expression using nucleofection, which achieves efficient transfection of primary keratinocytes (Supplementary Figure S1 online). Figure 4a–c illustrates that keratinocytes transfected with small interfering RNA (siRNA) directed against STIM1 exhibit a significant decrease in STIM1 mRNA and protein content 24 hours post transfection. Figure 4d shows that LPA-induced Ca2+ entry was impaired in STIM1 siRNA-transfected keratinocytes compared with scrambled siRNA-transfected cells.

Figure 4
Lysophosphatidic acid (LPA)-induced Ca2+ entry requires sufficient levels of STIM1 and functional Orai1. (ac) Relative efficiency of small interfering RNA (siRNA)-mediated STIM1 silencing compared to scrambled (scr) control by quantitative ...

The involvement of Orai1 in LPA-induced Ca2+ influx was investigated by evaluating the impact of overexpressing Orai1R91W, an Orai1 mutant that substantially attenuates Ca2+ entry through Orai1 channels through a dominant-negative effect (Liao et al., 2007). Figure 4e and f illustrates efficient transfection of Orai1-encoding plasmids to keratinocytes by nucleofection. As shown in Figure 4g, LPA-induced Ca2+ influx was inhibited in Orai1R91W-expressing keratinocytes, whereas entry levels were comparable in wild-type Orai1-expressing and empty vector–transfected cells. Notably, subsequent LPA-induced upregulation of NFAT transcriptional activity was found to be impaired in Orai1R91W-expressing cells, but not in wild-type Orai1- or empty vector–transfected cells (Figure 4h). A similar effect was observed following siRNA-mediated knockdown of Orai1 (Supplementary Figure S2 online).

LPA-induced keratinocyte migration requires STIM1, calcineurin, and NFAT2

To test the involvement of STIM1 in mediating LPA-induced keratinocyte migration, keratinocytes were subjected to STIM1 knockdown before performing three-dimensional (3D) chemotactic migration assays. Cells were allowed to migrate over 14 hours in medium containing 60 μx2133 Ca2+ or 1.2 mx2133 Ca2+ to mimic the contact of keratinocytes with LPA in high Ca2+o, as would occur following wounding of skin. As described previously, exposure to millimolar Ca2+o dampened overall migration rates (Figure 5a and b) (Magee et al., 1987). In both Ca2+o conditions, LPA treatment induced a significant increase in keratinocyte motility, as expected (Sauer et al., 2004). However, LPA-induced migration was significantly impaired in the 3D assays (Figure 5b) following STIM1 knockdown, suggesting that normal levels of STIM1 are required for LPA-induced keratinocyte motility.

Figure 5
Lysophosphatidic acid (LPA)-induced keratinocyte migration requires STIM1, calcineurin activity, and sufficient levels of nuclear factor of activated T cell 2 (NFAT2). (ad, h, i) Keratinocyte cultures were subjected to three-dimensional (3D) ...

To investigate the involvement of the calcineurin/NFAT pathway in mediating LPA-induced migration, cells were pretreated using the calcineurin inhibitor CsA before being subjected to two-dimensional scratch wounding (Supplementary Figure S3 online) and 3D chemotactic migration assays (Figure 5c and d). LPA-induced migration was significantly impaired in CsA-treated keratinocytes. Moreover, RNAi-mediated knockdown of NFAT2, the efficiency of which was verified by real-time PCR (Figure 5e) and western blotting (Figure 5f and g), significantly prevented the induction of 3D migration of keratinocytes by LPA in 60 μx2133 and 1.2 mx2133 Ca2+o (Figure 5h and i).

Discussion

The data presented in this paper (schematically summarized in Figure 6) demonstrate that stimulation of keratinocytes with LPA induces Ca2+o-regulated mobilization of Ca2+i, leading to the activation of calcineurin/NFAT2 signaling and keratinocyte migration. LPA stimulation in physiological millimolar Ca2+o evoked agonist-induced Ca2+ entry, which required sufficient levels of STIM1 and functional Orai1. Downstream of LPA-induced Ca2+ mobilization, we observed nuclear translocation of NFAT2 and activation of NFAT-dependent transcription. Finally, LPA-induced keratinocyte motility required sufficient levels of STIM1 and NFAT2 and calcineurin activity. Our study thus provides important insight into the signaling mechanism triggered by LPA to promote keratinocyte migration.

Figure 6
Proposed mechanism of lysophosphatidic acid (LPA)-induced Ca2+ signaling involved in promoting keratinocyte migration. On the basis of our results, this model proposes that in physiological conditions, LPA promotes migration of keratinocytes through ...

The physiology of keratinocytes is well known to be tightly regulated by Ca2+o (Tu et al., 2004). Consistent with this, our data show differential Ca2+ mobilization and NFAT activation upon stimulation with LPA in physiological millimolar Ca2+o compared with micromolar levels. Indeed, LPA induced Ca2+ entry when the Ca2+o was adjusted to 1.2 mx2133 simultaneously with or briefly before stimulation. However, keratinocytes left in 1.2 mx2133 Ca2+o for a prolonged time before LPA stimulation only exhibited store release, but no Ca2+ entry was detectable within the observed time span, which is in accordance with previous studies (Ross et al., 2007, 2008; Lichte et al., 2008) and suggests that prolonged exposure to millimolar Ca2+ results in the inhibition of acute LPA-induced Ca2+ entry. Our data indicating NFAT activation caused by Ca2+ entry are consistent with previous studies performed in other epithelial cell types, including prostate (Thebault et al., 2006) and kidney (Schlondorff et al., 2009) cells.

The role of store- and receptor-operated Ca2+ entry (SOCE/ROCE) during physiological activation of primary cells has not been extensively investigated, and thus there is little information on the roles of STIM and Orai proteins in primary cells except in hepatocytes, in which STIM1 and Orai1 are involved in mediating Ca2+ entry leading to agonist-induced oscillations (Jones et al., 2008). To our knowledge, the establishment of functional roles for STIM1 and Orai1 in primary keratinocytes as mediators of agonist-induced Ca2+ entry has previously been unreported. Our data showing that LPA-induced Ca2+ entry depends on normal levels of STIM1 and functional Orai1 are consistent with studies in which STIM1 knockdown (Hirano et al., 2009; Potier et al., 2009) and expression of dominant/negative Orai1R91W (Liao et al., 2007, 2008) lead to the inhibition of SOCE or ROCE in a variety of cell lines.

Our data concur with an increasing body of evidence indicating an emerging role for Ca2+ signaling as a critical regulator of cell motility in a variety of physiological and pathological contexts. For instance, STIM1 and Orai1 have been found to mediate agonist-induced Ca2+ entry and regulate Ca2+ flux–dependent cell migration in epithelial tumor cells (Yang et al., 2009) and vascular smooth muscle cells (Potier et al., 2009). In addition, functional inhibition of calcineurin and NFAT2 impaired the migration rate of epithelial tumor cells (Jauliac et al., 2002), and wound closure in scratched myocyte cultures was reduced by silencing NFAT2 expression (Chow et al., 2008).

NFAT transcription factors have been previously attributed to important roles in the control of keratinocyte growth and differentiation (Santini et al., 2001; Mammucari et al., 2005; Horsley et al., 2008) and in the response of keratinocytes to UV-mediated stress (Canning et al., 2006; Flockhart et al., 2008). In conclusion, our work underscores the importance of Ca2+ signaling and NFAT factors in the control of epidermal physiology and potentially in cutaneous wound healing.

Materials and Methods

Reagents

All chemicals were purchased from Sigma-Aldrich (Gillingham, UK) unless otherwise specified.

Cell culture and treatments

Normal human epidermal keratinocytes were isolated from redundant foreskins (Todd and Reynolds, 1998) or breast or abdominal skin (Jans et al., 2004), and primary cultures were expanded in human keratinocyte growth supplement EpiLife medium (Invitrogen, Paisley, UK). The study adhered to the Declaration of Helsinki protocols for use of human materials, was approved by the Newcastle and North Tyneside local ethics committee, and written informed patient consent was obtained. Keratinocytes were used between passage 2 and 5. Treatments with agonists were performed by diluting the agonists directly in medium. For inhibition of calcineurin activity, cells were pretreated with 1 μx2133 CsA (Calbiochem, San Diego, CA) for 1 hour before agonist challenge. The concentration of LPA used throughout the study was 10 μx2133, which is a generally accepted concentration (Ross et al., 2007, 2008; Lichte et al., 2008).

Ca2+ imaging

Keratinocytes seeded in Willco glass-bottomed dishes (Intracel, Royston, UK) were subjected to Ca2+i imaging using Fluo-4-AM (Invitrogen) or Fura-PE3-AM (Calbiochem) as described (Ross et al., 2007). Changes in Ca2+i were monitored at 10-second intervals with a Pathway HTS imaging system (Becton-Dickinson, Rockville, MD). Images were captured using an Olympus (Melville, NY) × 20 objective and a Hamamatsu 1394 (Hamamatsu, Japan) ORCA-ERA CCD camera. Fluo-4 was excited at 488 nm, collecting emitted fluorescence through a 515LP filter. Fura-PE3 was excited at 340 and 380 nm, and emitted fluorescence was collected through the 515LP filter. Quantification was performed using Volocity (Improvision, Coventry, UK). When using Fluo-4, changes in Ca2+i are expressed as the ratio of the initial fluorescence to the temporal fluorescence (Ft/F0). When using Fura-PE3, changes in Ca2+i are expressed as ratiometric measurements (F340 nm/F380 nm).

Dual imaging of Ca2+i and NFAT2-GFP

Keratinocytes transduced with NFAT2-GFP-delivering retroviruses (Flockhart et al., 2008) were seeded on Willco dishes. After 24 hours, the cells were loaded using 5 μx2133 FuraRed-AM (Invitrogen). Dual imaging was then performed using a Leica TCS SP2 confocal laser scanning microscope equipped with an argon laser (Leica, Milton Keynes, UK). Fluorescence excitation of GFP and FuraRed was performed with the 488-nm line of the laser. Fluorescence emission of GFP was collected through a 500–550-nm window of the detector, whereas FuraRed emission was collected through a 650–700-nm window. Images were captured with a × 63 Plan Apo objective (NA1.32) (Leica, Milton Keynes, UK) at 10-second intervals. Changes in Ca2+i are expressed as the inverted ratio of the initial fluorescence to the temporal fluorescence (1/(Ft/F0)). The nuclear-to-cytoplasmic ratio of NFAT2-GFP was assessed by outlining the nucleus and cytoplasm of each cell as separate region of interest, calculating the mean green fluorescence in each regions of interest and frame in Volocity. Nuclear-to-cytoplasmic ratios were then calculated in Microsoft Excel.

NFAT transcriptional activity assay

NFAT transcriptional activity was measured using an NFAT firefly luciferase reporter plasmid (pGL3; Promega, Southampton, UK), containing nine copies of an NFAT-binding site from the IL-4 promoter (5′-TGGAAAATT-3′) positioned 5′ to a minimal promoter from the α-myosin heavy-chain gene, gratefully obtained from J Molkentin, Cincinnati, OH (Wilkins et al., 2004). Transfection efficiency and cell viability were controlled by cotransfecting a Renilla luciferase control vector (pRLTK; Promega). Keratinocytes were seeded in 12-well plates and transfected using 0.5 μg of firefly reporter DNA plus 0.05 μg of Renilla luciferase DNA using Fugene 6 (Roche Applied Sciences, Burgess Hill, UK) at a 6:1 Fugene:DNA ratio. After 24 hours, the cells were stimulated as indicated, lysed, and assayed for dual luciferase activity. Luciferase assays were performed using the dual luciferase assay system (Promega). Reporter firefly luciferase values were normalized to the Renilla values.

RNA interference to knock down STIM1 and NFAT2 expression

Chemically modified (to prevent off-target effects) scrambled siRNA and NFAT2-specific siRNA were obtained from Qiagen (Crawley, UK) (Flockhart et al., 2009). STIM1-targeted siRNA (5′-GAAGCCUCUUAAGAAGUAG-3′ and 5′-AGACCUCAAUUACCAUGAC-3′) was obtained from Eurofins/MWG (Ebersberg, Germany). siRNA was transfected into keratinocytes using the Human Keratinocyte Nucleofector kit and device from Amaxa/Lonza (Cologne, Germany) according to the manufacturer's protocol (2 μg siRNA per 106 cells). For STIM1, 1 μg of each siRNA was used to transfect 106 cells. After 24 hours, the cells were trypsinized and subjected to the 3D chemotactic migration assay. Knockdown of STIM1 and NFAT2 was verified by real-time PCR and western blotting using standard techniques (Hampton et al., 2012) and anti-STIM1 antibody (clone 5A2; Abnova, Taipei, Taiwan) or anti-NFAT2 antibody (a kind gift from Dr Nancy Rice) (Hampton et al., 2012), respectively. For NFAT2 real time, Poly-A RNA was isolated using a Direct mRNA isolation kit (Sigma-Aldrich, Gillingham, UK), retrotranscribed using a High-Capacity cDNA RT kit (Applied Biosystems, Paisley, UK) and subjected to real-time PCR using iQ SYBR Green Supermix and a Chromo4 cycler (Bio-Rad, Hemel Hempstead, UK). Primers used to detect NFAT2 were 5′-CTTCTCCAACACCAAAGTCC-3′ (forward) and 5′-CGTACCCGTGTGTTCTTCCT-3′ (reverse). NFAT2 expression was normalized to glyceraldehyde-3-phosphate dehydrogenase expression (forward primer: 5′-GTCAGTGGTGGACCTGACCT-3′ and reverse primer: 5′-AGGGGTCTACATGGCAACTG-3′). For STIM1 real time, total RNA was isolated using the Arcturus PicoPure RNA Isolation kit (Applied Biosystems) and reverse transcribed using the SuperScript III First-Strand Synthesis System (Invitrogen); TaqMan gene-expression assays Hs00162394_m1 (STIM1) and Hs99999905_m1 (glyceraldehyde-3-phosphate dehydrogenase) (Applied Biosystems) were performed on a 7900HT system (Applied Biosystems).

Effect of dominant/negative Orai1R91W on LPA-induced Ca2+ entry

pCMV-myc plasmids encoding wild-type Orai1 or mutated dominant/negative Orai1R91W were kindly donated by Professor L Birnbaumer (Liao et al., 2007) (NIEHS, Research Triangle Park, NC). Keratinocytes (106 cells) were transfected by nucleofection with 2 μg of Orai1-encoding plasmid and 0.5 μg of pEGFP-N1 (Clontech, Mountain View, CA) to mark the transfected cells (Zarayskiy et al., 2007). The expression of myc-tagged Orai1-encoding plasmids was verified by standard western blotting using anti-myc antibody (clone 9E10; Santa Cruz Biotechnology, San Diego, CA). Cells were seeded into Willco dishes at 0.5 × 106 cells per dish. After 24 hours, the cells were processed for Ca2+i imaging using Fura-PE3. Before performing Ca2+ imaging, the sample field was analyzed for GFP expression using the appropriate filter sets.

Migration assays

Keratinocyte motility was assessed using standard two-dimensional scratch wounding and 3D chemotactic migration assays. Chemotactic migration of keratinocytes was assayed in a manner similar to that described in Sauer et al., 2004. Briefly, 20,000 keratinocytes were seeded on top of uncoated Transwell filters (12 mm diameter, 8 μm pore size; Corning Life Sciences, Schiphol-Rijk, The Netherlands) in a 10-μl drop. Care was taken to deposit the drop in the middle of the filter without it touching the plastic support walls, in order to prevent a meniscus effect causing unequal distribution. The cells were left to attach for 30 minutes at room temperature before adding 300 μl of EpiLife medium containing agonists into the lower compartment. The cells were left to migrate overnight at 37 °C before fixation using 4% (w/v) formaldehyde. Unmigrated cells were scraped off the top portion of the filters using cotton buds. The filters were stained using hematoxylin and eosin, cut out and mounted using DPX. The migrated cells were counted on a Leica photomicroscope using a × 10 objective (3–5 fields per sample).

Statistical analysis

Statistical analysis was performed using Prism 5 (GraphPad Software, San Diego, CA). Data represent mean±SEM. Experiments were repeated at least three times using different keratinocyte strains unless otherwise specified.

Acknowledgments

We thank Dr Jeff Molkentin and Dr Lutz Birnbaumer for sharing their constructs and the Wellcome Trust (Research Leave Fellowship to NJR, grant number 061178), the Psoriasis Association and Stiefel, a GSK Company, for funding. We thank Professor Tony Thody for his help during the early stages of the project and Carole Todd and Martina Elias for providing expert technical support. The research work leading to this paper was funded in part through an investigator-initiated grant by Stiefel, a GSK Company. Nick Reynolds' laboratory/research is supported by the NIHR-Newcastle Biomedical Research Centre. We thank the Departments of Paediatric Surgery, Plastic Surgery, and Urology, Newcastle upon Tyne Hospitals, NHS Foundation Trust for their help in recruiting patients.

Glossary

CsA
cyclosporin A
DES
diethylstilbestrol
LPA
lysophosphatidic acid
NFAT
nuclear factor of activated T cell
RNAi
RNA interference
SOCE
store-operated Ca2+ entry
STIM1
stromal interaction molecule 1
Tg
thapsigargin

Notes

The authors state no conflict of interest.

Footnotes

SUPPLEMENTARY MATERIAL

Supplementary material is linked to the online version of the paper at http://www.nature.com/jid

Supplementary Material

Supplementary Figures S1–S3

References

  • Al-Daraji WI, Grant KR, Ryan K, et al. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A. J Invest Dermatol. 2002;118:779–788. [PubMed]
  • Anliker B, Chun J. Cell surface receptors in lysophospholipid signaling. Semin Cell Dev Biol. 2004;15:457–465. [PubMed]
  • Baker DL, Morrison P, Miller B, et al. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA. 2002;287:3081–3082. [PubMed]
  • Balazs L, Okolicany J, Ferrebee M, et al. Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am J Physiol Regul Integr Comp Physiol. 2001;280:R466–R472. [PubMed]
  • Bikle DD, Ratnam A, Mauro T, et al. Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor. J Clin Invest. 1996;97:1085–1093. [PMC free article] [PubMed]
  • Canning MT, Nay SL, Pena AV, et al. Calcineurin inhibitors reduce nuclear localization of transcription factor NFAT in UV-irradiated keratinocytes and reduce DNA repair. J Mol Histol. 2006;37:285–291. [PubMed]
  • Chow W, Hou G, Bendeck MP. Glycogen synthase kinase 3beta regulation of nuclear factor of activated T-cells isoform c1 in the vascular smooth muscle cell response to injury. Exp Cell Res. 2008;314:2919–2929. [PubMed]
  • Corral RS, Iniguez MA, Duque J, et al. Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells. Oncogene. 2007;26:958–969. [PubMed]
  • Demoyer JS, Skalak TC, Durieux ME. Lysophosphatidic acid enhances healing of acute cutaneous wounds in the mouse. Wound Repair Regen. 2000;8:530–537. [PubMed]
  • Dobrydneva Y, Williams RL, Blackmore PF. Diethylstilbestrol and other nonsteroidal estrogens: novel class of store-operated calcium channel modulators. J Cardiovasc Pharmacol. 2010;55:522–530. [PubMed]
  • Dolmetsch RE, Lewis RS, Goodnow CC, et al. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature. 1997;386:855–858. [PubMed]
  • Eichholtz T, Jalink K, Fahrenfort I, et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J. 1993;291 (Part 3:677–680. [PubMed]
  • Flockhart RJ, Armstrong JL, Reynolds NJ, et al. NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma. Br J Cancer. 2009;101:1448–1455. [PMC free article] [PubMed]
  • Flockhart RJ, Diffey BL, Farr PM, et al. NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure. FASEB J. 2008;22:4218–4227. [PMC free article] [PubMed]
  • Frischauf I, Schindl R, Derler I, et al. The STIM/Orai coupling machinery. Channels (Austin) 2008;2:261–268. [PubMed]
  • Goetzl EJ, An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 1998;12:1589–1598. [PubMed]
  • Gwack Y, Feske S, Srikanth S, et al. Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes. Cell Calcium. 2007;42:145–156. [PubMed]
  • Hampton PJ, Jans R, Flockhart RJ, et al. Lithium regulates keratinocyte proliferation via glycogen synthase kinase 3 and NFAT2 (nuclear factor of activated T cells 2) J Cell Physiol. 2012;227:1529–1537. [PubMed]
  • Hirano K, Hirano M, Hanada A. Involvement of STIM1 in the proteinase-activated receptor 1-mediated Ca2+ influx in vascular endothelial cells. J Cell Biochem. 2009;108:499–507. [PubMed]
  • Horsley V, Aliprantis AO, Polak L, et al. NFATc1 balances quiescence and proliferation of skin stem cells. Cell. 2008;132:299–310. [PMC free article] [PubMed]
  • Inoue M, Kratz G, Haegerstrand A, et al. Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization. J Invest Dermatol. 1995;104:479–483. [PubMed]
  • Jans R, Atanasova G, Jadot M, et al. Cholesterol depletion upregulates involucrin expression in epidermal keratinocytes through activation of p38. J Invest Dermatol. 2004;123:564–573. [PubMed]
  • Jauliac S, Lopez-Rodriguez C, Shaw LM, et al. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol. 2002;4:540–544. [PubMed]
  • Jones BF, Boyles RR, Hwang SY, et al. Calcium influx mechanisms underlying calcium oscillations in rat hepatocytes. Hepatology. 2008;48:1273–1281. [PMC free article] [PubMed]
  • Liao Y, Erxleben C, Abramowitz J, et al. Functional interactions among Orai1, TRPCs, and STIM1 suggest a STIM-regulated heteromeric Orai/TRPC model for SOCE/Icrac channels. Proc Natl Acad Sci USA. 2008;105:2895–2900. [PubMed]
  • Liao Y, Erxleben C, Yildirim E, et al. Orai proteins interact with TRPC channels and confer responsiveness to store depletion. Proc Natl Acad Sci USA. 2007;104:4682–4687. [PubMed]
  • Lichte K, Rossi R, Danneberg K, et al. Lysophospholipid receptor-mediated calcium signaling in human keratinocytes. J Invest Dermatol. 2008;128:1487–1498. [PubMed]
  • Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005;5:472–484. [PubMed]
  • Magee AI, Lytton NA, Watt FM. Calcium-induced changes in cytoskeleton and motility of cultured human keratinocytes. Exp Cell Res. 1987;172:43–53. [PubMed]
  • Mammucari C, Tommasi di Vignano A, Sharov AA, et al. Integration of Notch 1 and calcineurin/NFAT signaling pathways in keratinocyte growth and differentiation control. Dev Cell. 2005;8:665–676. [PubMed]
  • Martin AC, Willoughby D, Ciruela A, et al. Capacitative Ca2+ entry via Orai1 and STIM1 regulates adenylyl cyclase type 8. Mol Pharmacol. 2009;75:830–842. [PubMed]
  • Mazereeuw-Hautier J, Gres S, Fanguin M, et al. Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity. J Invest Dermatol. 2005;125:421–427. [PMC free article] [PubMed]
  • Noguchi K, Herr D, Mutoh T, et al. Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol. 2009;9:15–23. [PubMed]
  • Potier M, Gonzalez JC, Motiani RK, et al. Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J. 2009;23:2425–2437. [PubMed]
  • Roedding AS, Li PP, Warsh JJ. Characterization of the transient receptor potential channels mediating lysophosphatidic acid-stimulated calcium mobilization in B lymphoblasts. Life Sci. 2006;80:89–97. [PubMed]
  • Ross K, Parker G, Whitaker M, et al. Inhibition of calcium-independent phospholipase A impairs agonist-induced calcium entry in keratinocytes. Br J Dermatol. 2008;158:31–37. [PMC free article] [PubMed]
  • Ross K, Whitaker M, Reynolds NJ. Agonist-induced calcium entry correlates with STIM1 translocation. J Cell Physiol. 2007;211:569–576. [PMC free article] [PubMed]
  • Sage SO, Merritt JE, Hallam TJ, et al. Receptor-mediated calcium entry in fura-2-loaded human platelets stimulated with ADP and thrombin. Dual-wavelengths studies with Mn2+ Biochem J. 1989;258:923–926. [PubMed]
  • Santini MP, Talora C, Seki T, et al. Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc Natl Acad Sci USA. 2001;98:9575–9580. [PubMed]
  • Sauer B, Vogler R, Zimmermann K, et al. Lysophosphatidic acid interacts with transforming growth factor-beta signaling to mediate keratinocyte growth arrest and chemotaxis. J Invest Dermatol. 2004;123:840–849. [PubMed]
  • Schindl R, Bergsmann J, Frischauf I, et al. 2-aminoethoxydiphenyl borate alters selectivity of Orai3 channels by increasing their pore size. J Biol Chem. 2008;283:20261–20267. [PubMed]
  • Schlondorff JS, Del Camino D, Carrasquillo R, et al. Trpc6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of Nfat-dependent transcription. Am J Physiol Cell Physiol. 2009;296:C558–C569. [PubMed]
  • Sekharam M, Cunnick JM, Wu J. Involvement of lipoxygenase in lysophosphatidic acid-stimulated hydrogen peroxide release in human HaCaT keratinocytes. Biochem J. 2000;346 (Part 3:751–758. [PubMed]
  • Thebault S, Flourakis M, Vanoverberghe K, et al. Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res. 2006;66:2038–2047. [PubMed]
  • Todd C, Reynolds NJ. Up-regulation of p21WAF1 by phorbol ester and calcium in human keratinocytes through a protein kinase C-dependent pathway. Am J Pathol. 1998;153:39–45. [PubMed]
  • Tu CL, Chang W, Bikle DD. The extracellular calcium-sensing receptor is required for calcium-induced differentiation in human keratinocytes. J Biol Chem. 2001;276:41079–41085. [PubMed]
  • Tu CL, Oda Y, Komuves L, et al. The role of the calcium-sensing receptor in epidermal differentiation. Cell Calcium. 2004;35:265–273. [PubMed]
  • Vassilieva EV, Gerner-Smidt K, Ivanov AI, et al. Lipid rafts mediate internalization of beta1-integrin in migrating intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2008;295:G965–G976. [PubMed]
  • Wilkins BJ, Dai YS, Bueno OF, et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res. 2004;94:110–118. [PubMed]
  • Yang S, Zhang JJ, Huang XY. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell. 2009;15:124–134. [PubMed]
  • Zakharov SI, Smani T, Dobrydneva Y, et al. Diethylstilbestrol is a potent inhibitor of store-operated channels and capacitative Ca(2+) influx. Mol Pharmacol. 2004;66:702–707. [PubMed]
  • Zarayskiy V, Monje F, Peter K, et al. Store-operated Orai1 and IP3 receptor-operated TRPC1 channel. Channels (Austin) 2007;1:246–252. [PubMed]
  • Zuo W, Chen YG. Specific activation of mitogen-activated protein kinase by transforming growth factor-beta receptors in lipid rafts is required for epithelial cell plasticity. Mol Biol Cell. 2009;20:1020–1029. [PMC free article] [PubMed]

Articles from NPG Open Access are provided here courtesy of Nature Publishing Group